Texas Children's’s BioCryst Pharmaceuticals BCRX Stock Holding History

Texas Children's’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-60,479	Closed	-$492K	–	6
2019 Q1	$492K	Buy	+60,479	New	+$518K	0.6%	24

Other funds holding BCRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Texas Children's's BCRX Position: Q2 2019 in Review

Texas Children's sold out of BioCryst Pharmaceuticals (BCRX) in Q2 2019, closing a stake of 60,479 shares — an estimated $492K sold.

Texas Children's first reported a position in BCRX in Q1 2019 and held it in 1 quarter. The position peaked at $492K in Q1 2019. 116 funds tracked by Wall St. Rank hold BCRX as of Q2 2019.

Texas Children's reported no remaining BioCryst Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Texas Children's sold 60,479 BioCryst Pharmaceuticals shares in Q2 2019, an estimated $492K.
Texas Children's first reported a position in BioCryst Pharmaceuticals in Q1 2019 and held it in 1 quarter.
Texas Children's's BioCryst Pharmaceuticals position peaked at $492K in Q1 2019.
116 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2019.

Based on Texas Children's's 13F filing for Q2 2019, filed 13 Aug 2019.